Bristol-Myers Squibb (NYSE: BMY) reported earnings on Jan. 26. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Bristol-Myers Squibb met expectations on revenues and missed expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded, and earnings per share grew significantly.

Gross margins increased, operating margins dropped, net margins expanded.

Revenue details
Bristol-Myers Squibb logged revenue of $5.45 billion. The 15 analysts polled by S&P Capital IQ foresaw revenue of $5.53 billion. Sales were 6.7% higher than the prior-year quarter's $5.11 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions.

EPS details
Non-GAAP EPS came in at $0.53. The 19 earnings estimates compiled by S&P Capital IQ predicted $0.55 per share on the same basis. GAAP EPS of $0.50 for Q4 were 78% higher than the prior-year quarter's $0.28 per share.

Source: S&P Capital IQ. Quarterly periods. Figures may be non-GAAP to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 74.9%, 200 basis points better than the prior-year quarter. Operating margin was 28.9%, 90 basis points worse than the prior-year quarter. Net margin was 15.6%, 610 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $5.23 billion. On the bottom line, the average EPS estimate is $0.61.

Next year's average estimate for revenue is $18.24 billion. The average EPS estimate is $1.98.

Investor sentiment
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Bristol-Myers Squibb is outperform, with an average price target of $32.40.

Can your portfolio provide you with enough income to last through retirement? You'll need more than Bristol-Myers Squibb. Learn how to maximize your investment income with this report: "Secure Your Future With 11 Rock-Solid Dividend Stocks." Click here for instant access to this free report.